Literature DB >> 203906

Perianal Paget's disease.

M R Lock, D R Katz, A Parks, J P Thomson.   

Abstract

Paget's disease involves the ducts of apocrine glands and the overlying epidermis and is considered to be locally neoplastic. It is capable of developing into invasive carcinoma and in this event the prognosis is poor. The perianal skin may be affected by Paget's disease. This is a rare disorder and the four patients who have been seen with this disease at St Mark's Hospital since 1930 are described.

Entities:  

Mesh:

Year:  1977        PMID: 203906      PMCID: PMC2496814          DOI: 10.1136/pgmj.53.626.768

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Anogenital (extramammary) Paget's disease. A clinicopathological study.

Authors:  E B HELWIG; J H GRAHAM
Journal:  Cancer       Date:  1963-03       Impact factor: 6.860

2.  Paget's disease of the anus secondary to a malignant papillary adenoma of the rectum.

Authors:  T C Arminski; R J Pollard
Journal:  Dis Colon Rectum       Date:  1973 Jan-Feb       Impact factor: 4.585

3.  Familial occurrence of extramammary Paget's disease.

Authors:  P G Kuehn; R Tennant; A R Brenneman
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

4.  Perianal Paget's disease.

Authors:  J H Linder; R T Myers
Journal:  Am Surg       Date:  1970-06       Impact factor: 0.688

  4 in total
  3 in total

1.  Radiotherapy for perianal Paget's disease.

Authors:  R S Brown; M F Spittle
Journal:  J R Soc Med       Date:  1998-02       Impact factor: 5.344

2.  Perianal Paget disease treated definitively with radiotherapy.

Authors:  J Mann; A Lavaf; A Tejwani; P Ross; H Ashamalla
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

Review 3.  Perianal Paget disease treated with wide excision and thigh skin flap reconstruction: a case report and review of literature.

Authors:  Kexin Shen; Hai Luo; Jun Hu; Zhongshi Xie
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.